I agree that this site is using cookies. You can find further informations here.
X
Aprikian, A.
397  results:
Search for persons X
?
1

PT44 Cost-Effectiveness of Olaparib Vs. Rucaparib for Patie..:

Yanev, I. ; Aprikian, A. ; Raizenne, B.L..
Value in Health.  26 (2023)  12 - p. S202 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Clinical validation of optimized neural network risk models..:

Paproski, R.J ; Pink, D.B ; Pham, D....
European Urology.  83 (2023)  - p. S91-S92 , 2023
Link: https://doi.org/10.1016/..
 
?
3

EPH27 Association between Prescribing Specialty and Treatme..:

Hu, J. ; Aprikian, A. ; Dragomir, A.
Value in Health.  26 (2023)  6 - p. S169 , 2023
Link: https://doi.org/10.1016/..
 
?
4

CO209 Association between Baseline Bone Mineral Density Tes..:

Hu, J. ; Aprikian, A. ; Dragomir, A.
Value in Health.  26 (2023)  6 - p. S54 , 2023
Link: https://doi.org/10.1016/..
 
?
5

CO142 Secondary Malignancies After Radiotherapy for Prostat..:

Quintana Barcena, P ; Aprikian, A ; Dragomir, A
Value in Health.  25 (2022)  12 - p. S45 , 2022
Link: https://doi.org/10.1016/..
 
?
6

HSD115 Utilization Trends of Novel Hormonal Agents in Metas..:

Hu, J ; Aprikian, A ; Saleh, R.
Value in Health.  25 (2022)  12 - p. S295 , 2022
Link: https://doi.org/10.1016/..
 
?
7

PCN229 POPULATION BASED ANALYSIS OF RATES OF USE OF NOVEL H..:

Hu, J. ; Aprikian, A. ; Vanhuyse, M..
Value in Health.  23 (2020)  - p. S63 , 2020
Link: https://doi.org/10.1016/..
 
?
8

PCN315 USE OF NOVEL HORMONAL AGENTS IN THE MONTH BEFORE DYI..:

Hu, J. ; Aprikian, A. ; Vanhuyse, M..
Value in Health.  22 (2019)  - p. S497 , 2019
Link: https://doi.org/10.1016/..
 
?
9

PCN314 POPULATION BASED STUDY OF BASELINE BONE DENSITY SCRE..:

Hu, J. ; Aprikian, A. ; Vanhuyse, M..
Value in Health.  22 (2019)  - p. S497 , 2019
Link: https://doi.org/10.1016/..
 
?
10

PCN52 ABIRATERONE VERSUS ENZALUTAMIDE IN THE POST-CHEMOTHER..:

Hu, J. ; Ouizzane, S. ; Aprikian, A...
Value in Health.  22 (2019)  - p. S445 , 2019
Link: https://doi.org/10.1016/..
 
?
11

PCN248 - USE OF CANCER DRUGS IN THE END-OF-LIFE IN MEN DYIN..:

Hu, J. ; Aprikian, A. ; Vanhuyse, M..
Value in Health.  21 (2018)  - p. S56 , 2018
Link: https://doi.org/10.1016/..
 
?
12

PCN300 - MODERN TRENDS OF ORCHIECTOMY FOR PROSTATE CANCER:

Hu, J. ; Aprikian, A. ; Dragomir, A.
Value in Health.  21 (2018)  - p. S65 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Bladder-Sparing Hypofractionated Intensity Modulated Radiat..:

Alrashidi, S.M. ; Souhami, L. ; Cury, F....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e84 , 2018
Link: https://doi.org/10.1016/..
 
?
14

PCN346 - DISEASE SPECIFIC COST ANALYSIS OF THE NONMETASTATI..:

Yanev, I. ; Aprikian, A. ; Nablsi, E....
Value in Health.  21 (2018)  - p. S73 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Cost-Utility Of Novel Tests After A Negative Prostate Biops:

Dragomir, A ; Palenius, E ; Aprikian, A...
Value in Health.  20 (2017)  9 - p. A590 , 2017
Link: https://doi.org/10.1016/..
 
1-15